Onion, D., Argent, R. H., Reece-Smith, A. M., Craze, M. L., Pineda, R. G., Clarke, P. A., . . . Grabowska, A. M. (2016). 3-dimensional patient-derived lung cancer assays reveal resistance to standards-of-care promoted by stromal cells but sensitivity to histone deacetylase inhibitors. American Association for Cancer Research.
Chicago Style (17th ed.) CitationOnion, David, et al. 3-dimensional Patient-derived Lung Cancer Assays Reveal Resistance to Standards-of-care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase Inhibitors. American Association for Cancer Research, 2016.
MLA (9th ed.) CitationOnion, David, et al. 3-dimensional Patient-derived Lung Cancer Assays Reveal Resistance to Standards-of-care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase Inhibitors. American Association for Cancer Research, 2016.